Product: Moexipril Hydrochloride and Hydrocholorothiazide Tablets USP, 7.5 mg/12.5 mg, 100-count bottle, Rx only, Distributed By: TEVA PHARMACEUTICALS USA, INC., North Wales, PA  19454, NDC 0093-5213-01.
Reason for recall: Failed Impurities/Degradation Specifications: High out of specification test result for the Moexipril Diketopiperazine impurity was obtained during routine stability testing.
Recall initiated: 20171214
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated